We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments... Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. Show more
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK, June 7, 2024 NEW YORK, June 7, 2024 /PRNewswire/...
PITTSBURGH, June 05, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in...
PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting...
PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in...
U.S. index futures indicate a positive opening in Monday’s pre-market, extending the robust gains achieved last week. At 06:36 AM, the futures for the Dow Jones Industrial Average...
Net product revenue of $45.3 million in 1Q and $95.9 million since AugustFirst patient dosed in inhaled KB707 study for locally advanced or metastatic tumors of the lungReceived Fast Track...
PITTSBURGH, May 02, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.17 | 1.52756360833 | 207.52 | 212.39 | 198 | 268294 | 204.51077287 | CS |
| 4 | 28.6 | 15.7065187545 | 182.09 | 214.98 | 176 | 314247 | 194.59602317 | CS |
| 12 | 49.18 | 30.4501269271 | 161.51 | 214.98 | 144.0001 | 407883 | 177.09520349 | CS |
| 26 | 81.14 | 62.6321883443 | 129.55 | 214.98 | 107.5 | 396193 | 164.63814907 | CS |
| 52 | 93.78 | 80.2155504234 | 116.91 | 214.98 | 93.95 | 343602 | 143.6678805 | CS |
| 156 | 149.76 | 245.790251108 | 60.93 | 214.98 | 38.8563 | 265525 | 105.89151605 | CS |
| 260 | 162.52 | 337.388416027 | 48.17 | 214.98 | 31.89 | 218672 | 91.29529135 | CS |
Monksdream
3 months ago
Monksdream
4 months ago
Monksdream
5 months ago
Monksdream
1 year ago
wiredawg
3 years ago
wiredawg
3 years ago
wiredawg
3 years ago
wiredawg
3 years ago
wiredawg
3 years ago
wiredawg
3 years ago
wiredawg
3 years ago
wiredawg
3 years ago
wiredawg
3 years ago
rynlrt
3 years ago
Fofo812
3 years ago
crudeoil24
3 years ago
rynlrt
3 years ago
Fofo812
3 years ago
crudeoil24
3 years ago
Trophy
5 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
